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Background.Success of many diagnostic and treatment processes are 
inextricably linked to the use of computerized technologyon the current stage of 
medicine development. The aim of the present study was to createthedecision 
support system (DSS) to predict the risk of adverse effects in persons with 
HIV/AIDS. 
Materials and methods.We usedimmunogenetic markers as prognostic criteria 
in patients with HIV infection in alternative serial Wald analysis, which allows 
summarize the individual prognostic indexes (PI) and when it reaches a threshold 
value with a certain probability argues about the character of the disease 
progression. Training matrix classes had between 12 and 61 realizations, which 
consisted of 8 recognition features: serum levels of IL-10, TNF-α (pg/ml), absolute 
number of CD4+ T lymphocytes (cells/μL); determination of IL-10 and TNF-
αgenesgenotype. Algorithm of functioning of the proposed DSS was based on the 
initial immunogenetic parameters values and the intersection of recognition classes 
characterizing the functional state of the disease process. 
Results.Inpredictingof adverseoutcomesinpersons with HIV we 
determinedthatreliablemodulatorsofsevere CNS lesionswereminorcarriergenotypeof 
IL-10 gene, heterozygousvariantof TNF-α gene,highlevels of IL-10 and  TNF-α in 
case of severe immunodeficiency. Prognostic index of these parameters was -15.32, 
corresponding up to 95 % of implementation forecast of organic CNS lesions in 
people living with HIV. 
Themostunfavorableindicatorsoftheriskofpulmonarytuberculosiscanberegardedas a 
combinationofheterozygousvariant of IL-10 gene,homozygousmajorallelevariantof 
TNF-αgene, serumlevelsof IL-10 (≥10.0 pg/ml) and TNF-α (≥1.0 pg/ml), T-helpers 
count ≤200 cells/μL(PI=-15.12, CI >95%). 
Prognosticsignificanceofriskfactorsforextrapulmonarytuberculosisinpatientswith HIV 
infectionweregenerallysimilarto modulatorofpulmonarytuberculosis: carrierof C/A 
genotypeof IL-10 gene, G/GgenotypeofTNF-α gene, highlevelsofcytokinesin 
combination with severeimmunosuppression (PI=-11.32,CI >90%). 
Implementingprognosisofherpesviralinfectionsweredetermined by thecombinationof 
IL-10 genehomozygousmajorallelevariantandheterozygousTNF-α gene variant 
withhighcytokineproductionandlowvaluesof CD4+ cells (PI=-10.26, CI >90%). 
Conclusions.The proposed mathematical model of the DSS may be offered for 
use in clinical practice to determine the risk of opportunistic infections in persons with 
HIV/AIDSand can better anticipate unintended consequences taking into account the 
individual immunogenetic features. 
